Lanzatech Global (LNZA) Q4 2024 earnings summary

Executive summary

• Reported full-year 2024 revenue of $49.6M, down from $62.6M in 2023, mainly due to project completions and delays in large biorefining projects.

• Net loss for 2024 was $137.7M, compared to $134.1M in 2023, with increased losses driven by non-cash expenses and lower revenue.

• Shifted operational focus from R&D to global deployment, aiming to sharpen business focus and improve cost structure.

• Management is evaluating liquidity initiatives, but substantial doubt remains about the company's ability to continue as a going concern.

Financial highlights

• Q4 2024 revenue was $12.0M, down from $20.5M in Q4 2023, due to project timing delays and prior period project completions.

• Gross profit for 2024 was $23.6M, up from $17.7M in 2023, with a Q4 2024 gross margin of 54% due to revenue mix.

• Operating expenses rose to $132.6M in 2024 from $124.0M in 2023, mainly from project-related costs expected to be recovered at FID.

• Adjusted EBITDA loss for 2024 was $88.2M, compared to $80.1M in 2023, reflecting increased losses from lower revenue.

• Cash, restricted cash, and investments totaled $58.1M at year-end 2024, down from $89.1M at the end of Q3 2024.

Outlook and guidance

• Several large projects, including Project Drake (EU) and a Norway site, remain underway and are expected to contribute to future revenue once transferred.

• LanzaTech expects additional LanzaJet shares to be issued with sublicensing events of its alcohol-to-jet technology.